tiprankstipranks
Iovance Biotherapeutics (IOVA)
NASDAQ:IOVA
IOVA
Iovance Biotherapeutics
RESEARCH TOOLSreports
Want to see IOVA full AI Analyst Report?

Iovance Biotherapeutics (IOVA) Revenue

4,122 Followers
StatisticsMarket CapRevenue

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had a revenue of 71.43M in the quarter ending Mar 31, 2026, with -17.68%. This bring the company's revenue in the last twelve months to 285.61M, Decreased 8.39%. In the fiscal year ending Dec 31, 2025, Iovance Biotherapeutics had annual revenue of 263.50M with 60.60% growth.
Revenue (ttm)
285.61M
Revenue Growth
34.26%
P/S Ratio
7.40
Revenue/Employee
$314,442
Employees
838
Market Cap
$1.95B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
263.50M99.43M+60.60%
Dec 31, 2024
164.07M162.88M+13,698.99%
Dec 31, 2023
1.19M―+∞%
Dec 31, 2022
―――
Dec 31, 2021
―――
Dec 31, 2020
―――
Dec 31, 2019
―――
Dec 31, 2018
―――
Dec 31, 2017
―――